Ali Shahbaz, MD
Dermatology · Austin, TXNPI 1336870138
Payments from drug & device makers
Across 1,012 payments — averaging $408.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$104K
- LEO Pharma Inc.$58K
- Galderma Laboratories, L.p.$57K
- Arcutis Biotherapeutics, Inc.$49K
- Sun Pharmaceutical Industries Inc.$45K
- Novartis$24K
- plus $75K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 184 | $104,155 |
| LEO Pharma Inc. | 69 | $57,793 |
| Galderma Laboratories, L.p. | 106 | $56,835 |
| Arcutis Biotherapeutics, Inc. | 49 | $49,327 |
| Sun Pharmaceutical Industries Inc. | 72 | $45,363 |
| Novartis | 43 | $24,338 |
| AbbVie | 114 | $13,323 |
| E.r. Squibb & Sons, L.L.C. | 55 | $13,138 |
| Amgen | 42 | $10,510 |
| Eli Lilly | 5 | $6,807 |
| Incyte Corporation | 26 | $6,610 |
| Johnson & Johnson(2 entities) | 71 | $5,511 |
| Pfizer | 5 | $5,056 |
| Dermavant Sciences, Inc. | 23 | $4,405 |
| Almirall LLC | 4 | $2,327 |
| Janssen Scientific Affairs, LLC | 8 | $2,167 |
| Organon | 11 | $1,888 |
| Regeneron Healthcare Solutions, Inc. | 37 | $1,014 |
| Lilly USA, LLC | 27 | $777 |
| Sanofi | 20 | $575 |
| Merz North America, Inc. | 4 | $382 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $151 |
| Mayne Pharma Commercial LLC | 7 | $142 |
| Biofrontera Inc. | 7 | $125 |
| Journey Medical Corporation | 6 | $124 |
| Botanix SB Inc | 2 | $44 |
| Cipher Pharmaceuticals US LLC | 1 | $30 |
| Revance Therapeutics, Inc. | 1 | $27 |
How this compares
$413,145 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Austin
- Edward LainAustin$12M
- Janet DuboisAustin$3.5M
- Daniel CarrascoAustin$1.4M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- David BushoreAustin$385K
- Blakely RichardsonAustin$279K
- Stephen TyringWebster$14.1M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.